Asset Management Resources, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Asset Management Resources, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 24, 2024	SELL	$775.18 - $881.7 $84,494 - $96,105	-109 Reduced 19.57%	448 $393,000
Q3 2023 Nov 02, 2023	SELL	$692.45 - $844.37 $10,386 - $12,665	-15 Reduced 2.62%	557 $458,000
Q2 2023 Jul 13, 2023	SELL	$700.03 - $830.35 $98,004 - $116,249	-140 Reduced 19.66%	572 $411,000
Q1 2023 Apr 10, 2023	SELL	$680.49 - $826.97 $110,239 - $133,969	-162 Reduced 18.54%	712 $585,000
Q4 2022 Feb 08, 2023	SELL	$705.89 - $766.39 $10,588 - $11,495	-15 Reduced 1.69%	874 $630,000
Q3 2022 Nov 10, 2022	BUY	$573.97 - $724.32 $16,645 - $21,005	29 Added 3.37%	889 $612,000
Q2 2022 Jul 15, 2022	SELL	$548.35 - $738.84 $51,544 - $69,450	-94 Reduced 9.85%	860 $508,000
Q1 2022 May 12, 2022	SELL	$595.12 - $698.43 $8,331 - $9,778	-14 Reduced 1.45%	954 $666,000
Q4 2021 May 11, 2022	BUY	$543.48 - $670.97 $526,088 - $649,498	968 New	968 $611,000

1,534

83.6M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $75.3B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Asset Management Resources, LLC, based on Form 13F filings with the SEC.

Stay updated on Asset Management Resources, LLC with notifications on news.